These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 27555077)

  • 1. Fatal Graft-Versus-Host Disease Following Adult-To-Adult Living Donor Liver Transplantation From an HLA Nonhomozygous Donor.
    Yu YD; Kim DS; Ha N; Jung SW; Han JH; Kim JY; Park SH; Cho YJ
    Prog Transplant; 2016 Dec; 26(4):394-396. PubMed ID: 27555077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fatal graft-versus-host disease after living donor liver transplantation: differential impact of donor-dominant one-way HLA matching.
    Kamei H; Oike F; Fujimoto Y; Yamamoto H; Tanaka K; Kiuchi T
    Liver Transpl; 2006 Jan; 12(1):140-5. PubMed ID: 16382466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Graft-versus-host disease following living donor liver transplantation.
    Soejima Y; Shimada M; Suehiro T; Hiroshige S; Gondo H; Takami A; Yasue S; Maehara Y
    Liver Transpl; 2004 Mar; 10(3):460-4. PubMed ID: 15004778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fatal graft-versus-host disease after living-donor liver transplantation from an HLA-DR-mismatched donor.
    Shimata K; Sakamoto R; Anan T; Uchida K; Honda M; Kouroki M; Urabe T; Hayashida S; Yamamoto H; Sugawara Y; Inomata Y
    Pediatr Transplant; 2017 Nov; 21(7):. PubMed ID: 28834141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Consequences of HLA Screening in the Prevention of Graft-Versus-Host Disease in Living Donor Liver Transplantation.
    Ercan LD; Durmaz Ö; Kaymakoğlu S; Önal Z; Büyükbabani N; Güllüoğlu M; Alper A; İbiş C; Cantez S; Yavru HA; Oğuz FS; Özden İ
    Pediatr Transplant; 2024 Sep; 28(6):e14846. PubMed ID: 39177044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unusual onset of chronic graft-versus-host disease after adult living-related liver transplantation from a homozygous donor.
    Nemoto T; Kubota K; Kita J; Shimoda M; Rokkaku K; Tagaya N; Fujiwara T; Sunakawa M
    Transplantation; 2003 Mar; 75(5):733-6. PubMed ID: 12640319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. One-way donor-recipient HLA-matching as a risk factor for graft-versus-host disease in living-related liver transplantation.
    Kiuchi T; Harada H; Matsukawa H; Kasahara M; Inomata Y; Uemoto S; Asonuma K; Egawa H; Maruya E; Saji H; Tanaka K
    Transpl Int; 1998; 11 Suppl 1():S383-4. PubMed ID: 9665021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute graft versus host disease following living donor liver transplantation: first Korean report.
    Cho EH; Suh KS; Yang SH; Lee HW; Cho JY; Cho YB; Yi NJ; Lee KU
    Hepatogastroenterology; 2007; 54(79):2120-2. PubMed ID: 18251173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical impact of donor against recipient HLA one way mismatch on the occurrence of graft versus host disease in liver transplantation.
    Kim SJ; Park S; Rhu J; Kim JM; Choi GS; Joh JW
    Sci Rep; 2022 Nov; 12(1):20337. PubMed ID: 36434131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relevance of HLA compatibility in living donor liver transplantation: the double-edged sword associated with the patient outcome.
    Uchiyama H; Kayashima H; Matono R; Shirabe K; Yoshizumi T; Ikegami T; Soejima Y; Matsuura T; Taguchi T; Maehara Y
    Clin Transplant; 2012; 26(5):E522-9. PubMed ID: 23061761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complete lymphoid chimerism and chronic graft-versus-host disease in an infant recipient of a hepatic allograft from an HLA-homozygous parental living donor.
    Whitington PF; Rubin CM; Alonso EM; McKeithan TW; Anastasi J; Hart J; Thistlethwaite JR
    Transplantation; 1996 Nov; 62(10):1516-9. PubMed ID: 8958284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FISH diagnosis of acute graft-versus-host disease following living-related liver transplant.
    Kanehira K; Riegert-Johnson DL; Chen D; Gibson LE; Grinnell SD; Velgaleti GV
    J Mol Diagn; 2009 Jul; 11(4):355-8. PubMed ID: 19460938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human leukocyte antigen and adult living-donor liver transplantation outcomes: an analysis of the organ procurement and transplantation network database.
    Jakab SS; Navarro VJ; Colombe BW; Daskalakis C; Herrine SK; Rossi S
    Liver Transpl; 2007 Oct; 13(10):1405-13. PubMed ID: 17902126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fatal graft-versus-host disease in recipient with pretransplant exposure to immune checkpoint inhibitors and donor-dominant one-way HLA matching after liver transplantation: A case report.
    Pang L; Wu WR; Xu LB; Liu C
    Int J Surg Case Rep; 2024 Oct; 123():110267. PubMed ID: 39265369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fatal graft-versus-host disease associated with transfusions of HLA-matched, HLA-homozygous platelets from unrelated donors.
    Benson K; Marks AR; Marshall MJ; Goldstein JD
    Transfusion; 1994 May; 34(5):432-7. PubMed ID: 8191569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Graft-versus-host disease after liver transplantation: documentation by fluorescent in situ hybridisation and human leucocyte antigen typing.
    Au WY; Ma SK; Kwong YL; Ng IO; Hawkins BR; Wan TS; Liu CL; Fan ST; Lo CM
    Clin Transplant; 2000 Apr; 14(2):174-7. PubMed ID: 10770425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Donor-dominant one-way matching of human leukocyte antigen-A/B/DR alleles predicts graft-versus-host disease following living donor liver transplantation.
    Hirata M; Yagi S; Shindo T; Yoshizawa A; Kiguchi G; Kaneshiro M; Yurugi K; Miyachi Y; Iwamura S; Yao S; Uemoto S
    Hepatol Res; 2021 Jan; 51(1):135-148. PubMed ID: 33034106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transfusion-associated graft-versus-host disease in a liver transplant recipient: an unusual presentation and review of the literature.
    O'Brien KL; Pereira SE; Wagner J; Shadman M; Hendrie P; Nelson K; Gernsheimer TB; Price T; Reyes JD; Nester T
    Transfusion; 2013 Jan; 53(1):174-80. PubMed ID: 22563807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Living-donor liver transplantation at the University of Tokyo, 1996-2011: the impact of HLA matching and a positive crossmatch on long-term survival and tolerance.
    Waki K; Sugawara Y; Mizuta K; Fujita H; Kadowaki T; Kokudo N
    Clin Transpl; 2011; ():223-35. PubMed ID: 22755416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of human leukocyte antigen mismatching on outcomes of living donor liver transplantation for primary biliary cirrhosis.
    Morioka D; Egawa H; Kasahara M; Jo T; Sakamoto S; Ogura Y; Haga H; Takada Y; Shimada H; Tanaka K
    Liver Transpl; 2007 Jan; 13(1):80-90. PubMed ID: 16964594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.